Shotwise
Wegovy, Ozempic, Mounjaro
Take control of your GLP-1 treatment journey with Shotwise, the ultimate companion app designed to simplify injection tracking and monitor your progress effortlessly. Shotwise helps you stay consistent, informed, and motivated.
Worldwide Release Date: January 9, 2025
Star Ratings(129 ratings | avg ★ 4.6)
App Store (129 ratings)
Total Downloads (Android)
100+
Last 28 days
Revenue
$922
AR
$11,064
MRR
$1,384
ARR
$16,608
Cash Flow Index
0.7x
Active Subscriptions
883
Active Trials
1
ARPAS
$1.04
Paid Subscriber Share (snapshot)
99.9%
Active Customers
688
New Customers
215
Subscription Penetration
128.3%
ARPU
$1.34
RPD
$1.34
ARPPU
$1.57
LTV
$16
MRR Growth (28d)
-7.5%
Subscriber Growth (28d)
-7.1%
All data is verified through RevenueCat. Last updated: Jun 15, 2026, 10:30:56 AM UTC.
App Screenshots
In-App Pricing
Tech Stack
About This Listing
A GLP-1 shot tracker app, low maintenance, huge market and potential for improvement. Also potential for expanded revenue through GLP-1 affiliates that is a huge opportunity but one I haven’t had the time or bandwidth to explore.
Asking Price
$27,680
Sale Details
Business Operations Started
Jan 2025
Assets Included in Sale
Source Code Included
Post-Sales Support
More apps for sale
Browse Marketplace ↗
Brainrot.mov
FOR SALELast 30 days rev
$16,436
MRR
$18,503
AbMaxx
FOR SALELast 30 days rev
$2,735
MRR
$1,376
Dawn: Quit Lust
FOR SALELast 30 days rev
$2,293
MRR
$1,840
Unlust
FOR SALELast 30 days rev
$1,356
MRR
$2,044
FitCal
FOR SALELast 30 days rev
$1,105
MRR
$7,126
Steps & Beasts
Last 30 days rev
$9,158
MRR
$2,126





